Biondo Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Biondo Investment Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,260	Closed	-$6.23M	–	90
2019 Q4	$6.23M	Buy	50,260 +12,526	+33%	+$1.12M	1.44%	18
2019 Q3	$2.5M	Sell	37,734 -339	-0.9%	-$22.8K	0.64%	43
2019 Q2	$3.03M	Buy	38,073 +103	+0.3%	+$9.22K	0.72%	42
2019 Q1	$4.25M	Buy	37,970 +17,945	+90%	+$1.96M	1.07%	33
2018 Q4	$2.02M	Sell	20,025 -10,370	-34%	-$1.07M	0.61%	39
2018 Q3	$3.84M	Buy	+30,395	New	+$3.22M	0.91%	35
2015 Q1	–	Sell	-2,200	Closed	-$343K	–	86
2014 Q4	$343K	Hold	2,200	–	–	0.1%	68
2014 Q3	$521K	Hold	2,200	–	–	0.16%	63
2014 Q2	$521K	Hold	2,200	–	–	0.16%	65
2014 Q1	$726K	Sell	2,200 -1,800	-45%	-$607K	0.24%	61
2013 Q4	$273K	Buy	+4,000	New	+$231K	0.09%	85

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Biondo Investment Advisors's ICPT Position: Q1 2020 in Review

Biondo Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 50,260 shares — an estimated $6.23M sold.

Biondo Investment Advisors first reported a position in ICPT in Q4 2013 and held it in 11 quarters. The position peaked at $6.23M in Q4 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

Biondo Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Biondo Investment Advisors sold 50,260 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $6.23M.
Biondo Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 11 quarters.
Biondo Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $6.23M in Q4 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Biondo Investment Advisors's 13F filing for Q1 2020, filed 8 May 2020.